- Home
- / Arix Bioscience
Arix Bioscience
Revenue
£112 K
FY, 2022
Arix Bioscience Summary
Company Summary
- Overview
- Arix Bioscience is a provider of venture capital funding services intended to build a group of healthcare and life science businesses.
- Type
- Subsidiary
- Status
- Closed
- Founded
- 2015
- HQ
- London, GB | view all locations
- Website
- https://arixbioscience.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Mark Chin, Managing Director
Andrew Smith, Non-Executive Director
Benny Soffer, Non-Executive Director
LocationsView all
2 locations detected
London, England HQ
United Kingdom
20 Berkeley Square, Mayfair
London, England
United Kingdom
Duke Street House, 50 Duke St
Arix Bioscience Financials
Summary Financials
- Revenue (H1, 2023)
- £27.0K
- Gross profit (H1, 2023)
- £27.0K
- Net income (H1, 2023)
- £12.5M
- Cash (H1, 2023)
- £101.0M
- EBIT (H1, 2023)
- (£3.0M)